Stocks rose Friday, with Wall Street headed to a fourth week of gains ahead of the long holiday weekend.» Read More
As the democratic presidential candidates prepare to square off on health care issues at tonight's debate in Ohio, a new federal study points to accelerating growth in government spending on Medicare over the next ten years, as baby boomers become eligible for the healthcare entitlement program.
Q: On Fast Money’s trader radar we look at the stock that was lighting up screens across Wall Street. Founded in 1887 in a former wallpaper factory, this company was the first maker of ready to use anti-bacterial surgical dressings. Now the maker of Tylenol, it is the world’s largest health products company. But this company doesn't just cure headaches, a medical journal announced Friday that the company’s Remicade drug is proving effective in the treatment of Crohn’s disease Who is it?
According to The Center for Responsive Politics' web site Pfizer Chairman and CEO Jeff Kindler has opened his wallet again for Sen. Hillary Clinton. You can see his latest "give" here. Twice now within the past year Kindler has given the maximum amount ($2,300) an individual can contribute to a candidate.
How much coffee can one woman drink? Watch me. I never drank coffee until I started covering the O.J. Simpson trial (come to think of it, I never drank much alcohol before then, either).
Warren Buffett's Berkshire Hathaway has accumulated an 8.6% stake in Kraft Foods, totaling over 132 million shares as of the end of the fourth quarter on December 31. That stake was worth $4.3 billion at that time. At today's closing price of $29.31, it's worth about $3.9 billion. EXPLORE WARREN BUFFETT'S INVESTMENTS WITH OUR NEW BERKSHIRE HATHAWAY PORTFOLIO TRACKER
Taking an extra day off to extend the long weekend before we go into a very busy period. Possibly a week from today (Friday) Genentech could get word from the Food and Drug Administration on its cancer drug Avastin for breast cancer. The agency could approve it, reject it or delay making a decision.
There was a mini-rally and spike in volume in shares of good ol' Dendreon this morning and early afternoon. The run-up occured ahead of CEO Dr. Mitchell Gold's presentation at the BIO CEO conference in New York City at 1:15 ET.
When the economy rebounds, where's your portfolio going to be? UBS says that's a question to answer right now. The bank released what it calls its "'New' Nifty Fifty," a list of 50 companies from around the world that can use today's troubling market conditions to position themselves to thrive when the economy rebounds. (PART 1)
The changes announced Monday have Cramer baffled.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Investors are worried about a recession again. So CNBC asked the experts for some recession-proof stock picks.
The medical device field has its problems -- but Jan Wald thinks the stocks of medical device makers may be excellent defensive plays in the current market environment. "Valuations of these stocks are pretty low at this point," the Stanford Group managing director told CNBC...
Standard and Poor's has just released the results of its twice-a-year stock screen, designed to find Warren Buffett-style stocks. The new list features several tech stocks, including Apple, as well as a number of names from Europe and Asia. But some key Buffett criteria aren't taken into account by the screen.
Stocks closed higher as investors appeared more enthused about Microsoft's bid for Yahoo! than they were concerned about the latest signs of economic weakness. The three major indexes each gained about 3-4 percent for the week, but the market still has a way to go to recover from January's rout.
As the markets continue to swing up and down, some of the biggest names in the Dow Industrials can be snapped up with fairly sizable yields.
Amgen reported on Thursday that its fourth-quarter profit edged higher, on a reversal of declining sales of its anemia drugs that have been hit with safety concerns and new restrictions on their use and insurance reimbursements.
Pfizer Wednesday reported a higher-than-expected fourth-quarter profit, helped by lower taxes, a weak dollar and growing demand for its drugs for nerve pain, kidney cancer and smoking cession.
The surprise rate cut coming from the Federal Reserve appeared to calm investors somewhat after dramatic drops overseas. What's the word on the Street?
A surprise Fed rate cut helped hold back a massive selloff in the stock market, although stocks closed lower on continued worries about the US economy.
Johnson & Johnson said Tuesday its fourth-quarter earnings rose almost 10 percent, beating forecasts, as the weak dollar propelled overseas sales of its drugs, medical devices and consumer products.
The global freefall in equities markets is likely to shake Wall Street Tuesday morning as investors shun stocks and search for safety plays.